comparemela.com

Stelara Crohn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biden Admin and U S Chamber Clash Over IRA Drug Pricing Impact

Today, the U.S. Department of Health and Human Services made its initial offers to pharmaceutical companies pursuant to the Biden Administration’s Inflation Reduction Act, which allows the U.S. Government to “negotiate” Medicare drug prices.

Johnson & Johnson Clocks 12% Q4 Revenue Growth, Led By Cancer and Crohn s Disease Drugs

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported fourth-quarter 2023 adjusted earnings of $2.29 per share, up 11.7% year-over-year, beating the consensus of $2.28. Sales increased 7.3% Y/Y to $21.4 billion, beating the consensus of $20.99 billion, with operational growth of 7.2% and adjusted operational growth of 5.7%. Operational growth, excluding the COVID-19 Vaccine, was 10.9%. Pharmaceutical segment sales increased by 4.2% to $13.72 billion. Darzalex (cancer drug) and Stelara (Crohn’s disea

New Johnson & Johnson s Q3 Earnings Beat Street View, Raises Annual Outlook - Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE: JNJ) has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the conse

US Medicare price negotiations powerful move to rein in healthcare costs: Experts

US Medicare price negotiations powerful move to rein in healthcare costs: Experts
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.